The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nexity SA
SWB:NQ9
|
FR |
|
Eurocash SA
OTC:EUSHF
|
PL |
|
Q
|
Quaker Chemical Corp
F:QUC
|
US |
|
Nexity SA
F:NQ9
|
FR |
|
G
|
Green Cross Medical Science Corp
KOSDAQ:142280
|
KR |
|
B
|
BNC Korea Co Ltd
KOSDAQ:256840
|
KR |
|
Hunan Warrant Pharmaceutical Co Ltd
SSE:688799
|
CN |
|
E
|
Eurocash SA
SWB:E07
|
PL |
|
Impact Silver Corp
XTSX:IPT
|
CA |
|
Eurocash SA
F:E07
|
PL |
|
M
|
Mohawk Industries Inc
F:MWK
|
US |
|
W
|
Widad Group Bhd
KLSE:WIDAD
|
MY |
|
RH
F:RS1
|
US |
|
Pernod Ricard SA
PAR:RI
|
FR |
|
A
|
Articore Group Ltd
OTC:RDBBF
|
AU |
|
Pernod Ricard SA
F:PER0
|
FR |
|
P
|
Pernod Ricard SA
F:PER
|
FR |
|
V
|
Vinci SA
XMUN:SQU
|
FR |
Nexity SA (NQ9)’s 12-month stock price forecast through May 2022 has a consensus target of €8.14, implying 81% downside. The forecast is based on price targets from 7 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
NQ9 is 8.14 EUR with a low forecast of 5.04 EUR and a high forecast of 10.47 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 0%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 3%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more